Cargando…
SB4 in the Era of Biosimilars: Clinical Data and Real-World Experience
A biosimilar is a biological medicinal product that is highly similar to an already authorized original biological medicinal product. The introduction of biosimilars may allow for a reduction in health care costs, due to discount pricing. Current clinical studies and real-world data suggest that the...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Mediterranean Journal of Rheumatology (MJR)
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280875/ https://www.ncbi.nlm.nih.gov/pubmed/32524079 http://dx.doi.org/10.31138/mjr.30.1.59 |